This study provides important insights into the anticancer potential of MAE, demonstrating its ability to reduce viability, modulate key molecular markers (p53, Ki-67, MMP-9, STAT-3), and affect multiple hallmarks of metastasis in MDA-MB-231 triple-negative breast cancer cells. This evidence concerns the gene MMP9 and triple-negative breast carcinoma.